孕妇寨卡病毒病严重程度、病毒载量与既往登革抗体和出生结局的关系
该研究分析里约热内卢母婴队列中131例寨卡病毒PCR阳性孕妇,评估母体临床严重程度、病毒载量及既往登革抗体与不良妊娠/婴儿结局的关联。结果显示疾病严重程度、病毒载量与不良结局无显著关联,既往登革抗体亦无关联。
要点
- 孕妇寨卡病毒病严重程度与不良出生结局无显著关联。
- 母体寨卡病毒载量与不良妊娠或婴儿结局无显著关联。
- 既往登革抗体存在与寨卡病毒病严重程度及不良结局无显著关联。
核心结论
- 先天性寨卡病毒综合征似乎与母体疾病严重程度、感染时寨卡病毒RNA载量或既往登革抗体存在无关。
研究设计与样本
- 研究为里约热内卢母婴队列分析,纳入131例寨卡病毒PCR阳性孕妇,其中125例有妊娠结局数据。
- 基于发热持续时间、皮疹严重程度、多系统受累和症状持续时间开发临床严重程度评估工具。
- 通过血液/尿液PCR循环数定量寨卡病毒RNA载量,基线测量登革IgG抗体,采用回归模型分析关联。
主要发现
- 131例孕妇中,6例(4.6%)为轻度疾病,98例(74.8%)为中度,27例(20.6%)为重度表现。
- 125例妊娠中58例(46.4%)出现不良结局,包括9例胎儿丢失(7.2%)。
临床怎么用
- 临床不应仅根据孕妇寨卡病毒病严重程度、病毒载量或既往登革抗体状态来预测不良出生结局风险。
- 所有寨卡病毒PCR阳性孕妇均需按规范进行妊娠期及婴儿出生后评估与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Congenital Zika virus (ZIKV) syndrome is a newly identified condition resulting from infection during pregnancy. We analyzed outcome data from a mother-infant cohort in Rio de Janeiro in order to assess whether clinical severity of maternal ZIKV infection was associated with maternal virus load, prior dengue antibodies, or abnormal pregnancy/infant outcomes. METHODS: A clinical severity assessment tool was developed based on duration of fever, severity of rash, multisystem involvement, and duration of symptoms during ZIKV infection. ZIKV-RNA load was quantified by polymerase chain reaction (PCR) cycles in blood/ urine. Dengue immunoglobulin G (IgG) antibodies were measured at baseline. Adverse outcomes were defined as fetal loss or a live infant with grossly abnormal clinical or brain imaging findings. Regression models were used to study potential associations. RESULTS: 131 ZIKV-PCR positive pregnant women were scored for clinical disease severity, 6 (4.6%) had mild disease, 98 (74.8%) had moderate disease, and 27 (20.6%) severe manifestations of ZIKV infection. There were 58 (46.4%) abnormal outcomes with 9 fetal losses (7.2%) in 125 pregnancies. No associations were found between: disease severity and abnormal outcomes (P = .961; odds ratio [OR]: 1.00; 95% confidence interval [CI]: 0.796-1.270); disease severity and viral load (P = .994); viral load and adverse outcomes (P = .667; OR: 1.02; 95% CI: 0.922-1.135); or existence of prior dengue antibodies (88% subjects) with severity score, ZIKV-RNA load or adverse outcomes (P = .667; OR: 0.78; 95% CI: 0.255-2.397). CONCLUSIONS: Congenital ZIKV syndrome does not appear to be associated with maternal disease severity, ZIKV-RNA load at time of infection or existence of prior dengue antibodies.
引用
- Halai UA, Nielsen-Saines K, Moreira ML, et al. Maternal Zika Virus Disease Severity, Virus Load, Prior Dengue Antibodies, and Their Relationship to Birth Outcomes. Clin Infect Dis. 2017. PMID: 28535184. doi:10.1093/cid/cix472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。